Tower Research Capital »

Gain Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.2k 1.7k 1.28
2024-03-31 $18k 4.6k 3.77
2023-09-30 $9.4k 2.9k 3.28
2023-06-30 $20k 4.3k 4.48
2023-03-31 $32k 6.8k 4.74
2022-12-31 $23k 7.2k 3.20
2022-09-30 $17k 5.3k 3.28
2022-06-30 $3.2k 716 4.42
2022-03-31 $2.0k 593 3.37
2021-12-31 $8.2k 1.2k 7.04
2021-09-30 $4.0k 555 7.21
2021-06-30 $0 72 0.00